advertisement

Diabetes

14 July 2010

Glaxo to pay $460 mln in settlement

GlaxoSmithKline Plc has agreed to pay about $460 million to resolve a majority of the lawsuits alleging its Avandia diabetes drug caused heart attacks and strokes.

0

GlaxoSmithKline Plc has agreed to pay about $460 million to resolve a majority of the lawsuits alleging its Avandia diabetes drug caused heart attacks and strokes, Bloomberg News reported on Tuesday.

Glaxo has agreed to settle about 10,000 cases at an average of at least $46,000 each, the report said, citing unnamed sources.

Analysts estimate the drugmaker faces about 13,000 Avandia lawsuits alleging personal injuries.

A Glaxo spokeswoman declined to comment.

The report comes as Glaxo defended Avandia's safety during a two-day meeting of U.S. health advisers who are weighing whether the medicine is too dangerous to stay on the market. (Reuters Health – 13 July 2010)

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

Diabetes expert

Dr. May currently works as a fulltime endocrinologist and has been in private practice since 2004. He has a variety of interests, predominantly obesity and diabetes, but also sees patients with osteoporosis, thyroid disorders, men's health disorders, pituitary and adrenal disorders, polycystic ovaries, and disorders of growth. He is a leading member of several obesity and diabetes societies and runs a trial centre for new drugs.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules